Five AAAAI Members Keep a Vital Drug Allergy Resource Current for the Entire Specialty

Drug allergy is an area of allergy/immunology that evolves faster than many clinicians can track. New studies, emerging therapies and shifting practice patterns mean that staying current is both essential and challenging. AAAAI members have taken the lead in ensuring the specialty has access to an up-to-date, high-quality resource designed specifically for real-world practice.

In November, the 2025 Update to The Journal of Allergy and Clinical Immunology: In Practice (JACI: In Practice) Drug Allergy Resources was published online, providing essential new articles and resources in drug allergy for the practicing allergist/immunologist. If it wasn’t for a small group of AAAAI volunteers, this yearly update wouldn’t be possible.

The Drug Allergy Resources began as a Presidential Initiative of Thomas A. Fleisher, MD, FAAAAI, in 2016. That work ultimately led to the publication of Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs in 2020 to help healthcare professionals provide optimal care to drug allergic patients. After its publication though, some of the authors and JACI: In Practice editors realized that because new drug allergy studies were being published so frequently, the new guide could become outdated very quickly.

Anna R. Wolfson, MD, FAAAAI

Five AAAAI members stepped in to ensure that would not happen. Autumn C. Guyer, MD, FAAAAI; Allison E. Norton, MD, FAAAAI; Allison Ramsey, MD, FAAAAI; Christine RF Rukasin, MD, FAAAAI; and Anna R. Wolfson, MD, FAAAAI, volunteered to update this important resource on a yearly basis.

“It is my honor to update the resources for the JACI: In Practice drug allergy guide every fall. I hope that other allergist/immunologists find this to be a helpful resource to navigate drug allergy scenarios in their clinical practice,” Dr. Wolfson said.

Autumn C. Guyer, MD, FAAAAI

Dr. Guyer volunteered for this project because she understands how important it is for clinicians to have access to the most current, evidence-based guidance on managing drug allergies. “This curated annual update, featuring a list of updated references on 11 commonly encountered drug classes, helps standardize care, improve patient safety and keep clinicians informed on the latest evidence-based practices."

For Dr. Norton, collaborating with so many national experts in drug allergy has been both rewarding and inspiring. “I joined this project to help build a trustworthy evidence-based tool for guiding clinical care in drug and vaccine allergy. This resource strengthens our specialty by offering expert-reviewed literature and practical commentary to support allergists in diagnosing and treating patients.”

“The Drug Allergy Resource collection is carefully curated by drug allergy experts. It’s a high-yield place to stay current in this important area of our field.”

Allison Ramsey, MD, FAAAAI

Christine RF Rukasin, MD, FAAAAI

Dr. Rukasin has no plans to stop working on this yearly resource update, which she says is a vital, time-saving resource for healthcare professionals. “This resource offers quick access to key findings—useful for point-of-care decisions, a teaching tool, or staying current on emerging trends without sifting through all the literature,” she explained. “Drug allergy is a rapidly evolving field that has a meaningful impact on patient outcomes and quality of life, and I’m proud to be part of a specialty working hard to translate research into real-world improvements for patients.”